N Anthony Coles Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

CERE Quotes by TradingView

N Anthony Coles is of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 25,928 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

N ANTHONY COLES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2024
SELL
Sale (or disposition) back to the issuer
-
25,928 Reduced 100.0%
0 Common Stock
Jul 01 2024
SELL
Open market or private sale
$1,029,500 $41.18 p/Share
25,000 Reduced 49.09%
25,928 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
$87,500 $3.5 p/Share
25,000 Added 32.93%
50,928 Common Stock
Jun 05 2024
BUY
Grant, award, or other acquisition
-
10,290 Added 28.41%
25,928 Common Stock
Jun 03 2024
SELL
Open market or private sale
$2,030,500 $40.61 p/Share
50,000 Reduced 76.18%
15,638 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$175,000 $3.5 p/Share
50,000 Added 43.24%
65,638 Common Stock
May 10 2024
SELL
Open market or private sale
$2,105,000 $42.1 p/Share
50,000 Reduced 76.18%
15,638 Common Stock
May 10 2024
BUY
Exercise of conversion of derivative security
$175,000 $3.5 p/Share
50,000 Added 43.24%
65,638 Common Stock
Apr 01 2024
SELL
Open market or private sale
$2,116,500 $42.33 p/Share
50,000 Reduced 76.18%
15,638 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$175,000 $3.5 p/Share
50,000 Added 43.24%
65,638 Common Stock
Mar 04 2024
SELL
Open market or private sale
$2,050,500 $41.01 p/Share
50,000 Reduced 76.18%
15,638 Common Stock
Mar 04 2024
BUY
Exercise of conversion of derivative security
$175,000 $3.5 p/Share
50,000 Added 43.24%
65,638 Common Stock
Feb 29 2024
SELL
Open market or private sale
$2,057,999 $41.16 p/Share
50,000 Reduced 76.18%
15,638 Common Stock
Feb 29 2024
BUY
Exercise of conversion of derivative security
$175,000 $3.5 p/Share
50,000 Added 43.24%
65,638 Common Stock
Feb 07 2024
SELL
Open market or private sale
$104,099 $41.54 p/Share
2,506 Reduced 13.81%
15,638 Common Stock
Feb 06 2024
BUY
Exercise of conversion of derivative security
-
15,440 Added 45.97%
18,144 Common Stock
Jan 02 2024
SELL
Open market or private sale
$2,112,000 $42.24 p/Share
50,000 Reduced 94.87%
2,704 Common Stock
Jan 02 2024
BUY
Exercise of conversion of derivative security
$175,000 $3.5 p/Share
50,000 Added 48.68%
52,704 Common Stock
Nov 14 2023
SELL
Open market or private sale
$573,567 $25.13 p/Share
22,824 Reduced 89.41%
2,704 Common Stock
Nov 14 2023
BUY
Exercise of conversion of derivative security
$79,884 $3.5 p/Share
22,824 Added 47.2%
25,528 Common Stock
Nov 08 2023
SELL
Open market or private sale
$2,516 $25.16 p/Share
100 Reduced 3.57%
2,704 Common Stock
Nov 08 2023
BUY
Exercise of conversion of derivative security
$350 $3.5 p/Share
100 Added 3.44%
2,804 Common Stock
Nov 07 2023
SELL
Open market or private sale
$677,441 $25.02 p/Share
27,076 Reduced 90.92%
2,704 Common Stock
Nov 07 2023
BUY
Exercise of conversion of derivative security
$94,766 $3.5 p/Share
27,076 Added 47.62%
29,780 Common Stock
Nov 03 2023
SELL
Open market or private sale
$1,561,427 $25.43 p/Share
61,401 Reduced 95.78%
2,704 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
Director
REGN
REGENERON PHARMACEUTICALS, INC. Healthcare
Director
YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
Executive Chair
NAC

N Anthony Coles

Cambridge, MA

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CERE